Design and characterization of a novel lytic protein against Clostridium difficile

被引：0
作者：
Meng Wang
Zifeng Deng
Yanmei Li
Yi Ma
Jufang Wang
机构：
[1] South China University of Technology,School of Biology and Biological Engineering
[2] South China University of Technology,Guangdong Key Laboratory of Fermentation and Enzyme Engineering
来源：
Applied Microbiology and Biotechnology | 2022年 / 106卷
关键词：
Lytic protein; Autolysin; Antibiotic; infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4511 / 4521
页数：10
相关论文
共 50 条
[21]   Direct detection and characterization of Clostridium difficile from a novel collection device to improve laboratory workflow [J].
Barbanti, Fabrizio ;
Spigaglia, Patrizia .
APMIS, 2019, 127 (06) :449-453
[22]   Functional Characterization of Clostridium difficile Spore Coat Proteins [J].
Permpoonpattana, Patima ;
Phetcharaburanin, Jutarop ;
Mikelsone, Anna ;
Dembek, Marcin ;
Tan, Sisareuth ;
Brisson, Marie-Clemence ;
La Ragione, Roberto ;
Brisson, Alain R. ;
Fairweather, Neil ;
Hong, Huynh A. ;
Cutting, Simon M. .
JOURNAL OF BACTERIOLOGY, 2013, 195 (07) :1492-1503
[23]   Future novel therapeutic agents for Clostridium difficile infection [J].
Koo, Hoonmo L. ;
Garey, Kevin W. ;
DuPont, Herbert L. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (07) :825-836
[24]   Novel antibiotics in development to treat Clostridium difficile infection [J].
Basseres, Eugenie ;
Endres, Bradley T. ;
Dotson, Kierra M. ;
Alam, M. Jahangir ;
Garey, Kevin W. .
CURRENT OPINION IN GASTROENTEROLOGY, 2017, 33 (01) :1-7
[25]   Clostridium difficile: novel insights on an incessantly challenging disease [J].
Tschudin-Sutter, Sarah ;
Widmer, Andreas F. ;
Perl, Trish M. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (04) :405-411
[26]   Functional analysis of SleC from Clostridium difficile: an essential lytic transglycosylase involved in spore germination [J].
Gutelius, Danielle ;
Hokeness, Kirsten ;
Logan, Susan M. ;
Reid, Christopher W. .
MICROBIOLOGY-SGM, 2014, 160 :209-216
[27]   Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection [J].
Zhanel, George G. ;
Walkty, Andrew J. ;
Karlowsky, James A. .
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2015, 26 (06) :305-312
[28]   Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile [J].
Miesel, Lynn ;
Hecht, David W. ;
Osmolski, James R. ;
Gerding, Dale ;
Flattery, Amy ;
Li, Fangbiao ;
Lan, Jing ;
Lipari, Philip ;
Polishook, Jon D. ;
Liang, Lianzhu ;
Liu, Jenny ;
Olsen, David B. ;
Singh, Sheo B. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) :2387-2392
[29]   In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile [J].
Mathur, Tarun ;
Barman, Tarani Kanta ;
Kumar, Manoj ;
Singh, Diksha ;
Kumar, Ram ;
Khera, Manoj Kumar ;
Yamada, Makiko ;
Inoue, Shin-ichi ;
Upadhyay, Dilip Jatashankar ;
Masuda, Nobuhisa .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
[30]   Curcumin: A natural derivative with antibacterial activity against Clostridium difficile [J].
Mody, Deepansh ;
Athamneh, Ahmad I. M. ;
Seleem, Mohamed N. .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 :154-161
12345